Tristan VanDeventer is a partner in the Capital Markets Group. Tristan represents public and private companies, investment banks, and private equity funds on a wide range of capital markets and strategic corporate transactions. He regularly advises clients on the full spectrum of complex finance and capital markets transactions, including initial public offerings and follow-ons, high yield and investment grade debt offerings, convertible and exchangeable note offerings, PIPE transactions and liability management transactions. In addition, Tristan counsels public company clients on compliance with securities laws, stock exchange rules and regulations, and corporate governance matters.
Tristan’s experience prior to Paul, Weiss includes:
Equity Offerings
- The underwriters in the $1.3 billion initial public offering of Arxis
- The underwriters in the $463 million initial public offering of Lumexa Imaging Holdings
- The underwriters in multiple secondary offerings for TPG
- BRP and Bain Capital in multiple secondary offerings
- The underwriters in the $200 million follow-on offering by Rhythm Pharmaceuticals
- KinderCare Learning Companies and its sponsor Partners Group in its $576 million initial public offering
- Affiliates of TSG Consumer Partners in multiple secondary offerings for Dutch Bros
- National Amusements in a $125 million preferred equity investment by BDT Capital Partners
- The Duckhorn Portfolio and its sponsor TSG Consumer Partners in its $300 million initial public offering and multiple secondary offerings
- The underwriters in the $240 million secondary offering by Amkor Technology
- Lilium Air Mobility in its $119 million equity offering
- McAfee and its sponsor in its $740 million initial public offering and subsequent follow-on offering
- Dragoneer Investment Group in the initial public offerings of multiple special purpose acquisition companies
- The underwriters in the $600 million public offering by Madrigal Pharmaceuticals
- The underwriters in multiple secondary offerings by Avantor
- The lead underwriters in multiple capital markets transactions by Biohaven
- The underwriters in the $125 million public offering by 2seventy bio
Debt Offerings
- Neogenomics in its $316 million offering of convertible senior notes
- IQVIA in its offerings of senior high-yield notes and senior secured investment grade notes
- Viridian Therapeutics in its $225 million offering of convertible senior notes
- The underwriters in high-yield and investment grade senior green notes, junior subordinated green notes and exchangeable green notes offerings for HA Sustainable Infrastructure
- Altice France in connection with its €24 billion debt restructuring
- Surgery Partners and its sponsor Bain Capital in multiple senior high-yield notes offerings
- LPL Financial in multiple offerings of senior high-yield notes
- Alnylam Pharmaceuticals in its $661 million offering of convertible senior notes
- Seagate Technology Holdings in its $1.5 billion offering of exchangeable senior notes
- NFP in multiple senior high-yield notes offerings
- U.S. Acute Care Solutions in its $800 million offering of senior secured high-yield notes
- The Michaels’ Companies in its $500 million senior secured high-yield notes offering
- U.S. Renal Care in its $500 million offering of senior high-yield notes
- Truck Hero in its $335 million senior high-yield notes offering
- Wolfspeed (formerly Cree) in its offering of $575 million of convertible senior notes
Mergers & Acquisitions
- The Duckhorn Portfolio in its:
- $1.95 billion take-private sale to Butterfly Equity
- $400 million acquisition of Sonoma-Cutrer Vineyards from Brown Forman
- Affiliates of Dragoneer Investment Group in securities matters related to the take-private of Arco Platform
- McAfee in capital markets matters related to its $14 billion take-private sale to a private equity consortium led by Advent International
- Integrated Device Technologies in its $6.7 billion sale to Renesas
- Branch Analytics in its acquisition of TUNE’s attribution analytics platform
